Investors won’t buy your stock if they think your CEO is going to croak the following year. After the WWDC conference in June, Apple reps blamed Jobs’ more than unusual thin build on an unspecified illness that required antibiotic treatment. Despite repeated requests, company officials are not commenting on the status of Jobs’ ailment.
Jobs is a survivor of pancreatic cancer and also happens to be one of the most powerful people in business. As such, his health is of great concern for those who care for nothing more than their wallet size.
For a visionary chief executive like Jobs – who drives the development of Apple’s hit products – health is a material factor in the company’s performance, and something investors should know about ASAP.
Well, no one lives forever. So, where will Apple be after Steve Jobs?